Celecoxib: evaluation of its efficacy and safety in the second decade of the 21st century
https://doi.org/10.14412/1996-7012-2013-2439
Abstract
Celecoxib is an effective drug to control chronic pain in rheumatic diseases. It is the only nonsteroidal antiinflammatory drug that has clearly shown the lower frequency of not only upper, but also distal gastrointestinal complications, such as iron-deficiency anemia associated with small bowel pathology. In real clinical practice, the reflection of which is populationbased studies, celecoxib causes cardiovascular events relatively rarely. Its good tolerability and a low risk for gastrointestinal and cardiovascular complications allow its successful use for a long time (if required), without fear of drug-induced complications.
About the Author
Andrei Evgenyevich Karateev
V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. <div><p>Боль (практическое руководство для врачей). Под ред. Яхно НН, Кукушкина МЛ. Москва: Издательство РАМН; 2012. 512 c. [Bol' (prakticheskoe rukovodstvo dlya vrachey). Yakhno NN, Kukushkina ML, editors. Moscow: Izdatel'stvo RAMN; 2012. 512 p.]</p><p>McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013;10(2):e1001388. DOI: 10.1371/journal.pmed.1001388. Epub 2013 Feb 12.</p><p>drugs.com [интернет] U.S. Pharmaceutical Sales - 2012 [доступ 02.10.2013]. Available from: http://www.drugs.com/stats/top100/2012/units</p><p>Каратеев АЕ. Использование целекоксиба в ревматологии, кардиологии, неврологии и онкологии. Русский медицинский журнал. 2007;15(22);1660–9. [Karateev AE. Ispol'zovanie tselekoksiba v revmatologii, kardiologii, nevrologii i onkologii. Russkiy meditsinskiy zhurnal. 2007;15(22);1660–9.]</p><p>Patel M, Arber N, Eagle C et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med. 2006;355(9):885–95.</p><p>Bertagnolli M, Eagle C, ZauberA et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006;355(9):873–84. DOI: http://dx.doi.org/10.1056%2FNEJMoa061355.</p><p>Koo BK, Km YS, Park KW et al. Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study. Lancet. 2007;370(9587):567–74.</p><p>Saudan M, Saudan P, Perneger T et al. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Joint Surg Br. 2007;89(2):155–9. DOI: http://dx.doi.org/10.1302%2F0301-620X.89B2.17747.</p><p>Lyketsos C, Breitner J, Green R et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. ADAPT Research Group. Neurology. 2007;68(21):1800–8.</p><p>Cudkowicz M, Shefner J, Schoenfeld D et al. Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol. 2006;60(1):22–31. DOI: http://dx.doi.org/10.1002%2Fana.20903.</p><p>Müller N, Krause D, Dehning S et al. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res. 2010;121(1-3):118–24. DOI: http://dx.doi.org/10.1016%2Fj.schres.2010.04.015.</p><p>Sommer I, de Witte L, Begemann M, Kahn R. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry. 2012;73(04):414–9. DOI: http://dx.doi.org/10.4088%2FJCP.10r06823.</p><p>Malmstrom K, Fricke J, Kotey P et al. A comparison of rofecoxib versus celecoxb in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model. Clin Ther. 2002;24(10):1549–60. DOI: http://dx.doi.org/10.1016%2FS0149-2918%2802%2980059-5.</p><p>Cheung R, Krishnaswami S, Kowalski K. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study. Clin Ther. 2007;29 Suppl:2498–510. DOI: 10.1016/j.clinthera.2007.12.008.</p><p>Gimbel J, Brugger A, Zhao W et al. Efficacy and tolerability of celecoxb versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther. 2001;23(2):228–41. DOI: http://dx.doi.org/10.1016%2FS0149-2918%2801%2980005-9.</p><p>Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand. 2004;48(5):525–46.</p><p>Chen L, Elliott R, Ascroft D. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain. J Clin Pharm Ther. 2004;29(3):215–29. DOI: http://dx.doi.org/10.1111%2Fj.1365-2710.2004.00558.x.</p><p>Straube S, Derry S, McQuay H, Moore R. Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies. Acta Anaesthesiol Scand. 2005;49(5):601–13. DOI: http://dx.doi.org/10.1111%2Fj.1399-6576.2005.00666.x.</p><p>Derry S, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2012 Mar 14;3:CD004233. DOI: 10.1002/14651858.CD004233.pub3.</p><p>Dietrich I, Ralha L, Chahade W et al. Efficacy and tolerability of celecoxib 200 mg bid ver-sus diclofenac 75 mg bid in acute low back pain. Ann Rheum Dis. 2006;65(Suppl II):238.</p><p>Petri M, Hufman S, Waser G et al. Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. J Rheumatol. 2004;31:1614–20.</p><p>Schumacher HR, Berger MF, Li-Yu J et al. Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial. J Rheumatol. 2012 Sep;39(9):1859-66. DOI: 10.3899/jrheum.110916. Epub 2012 Aug 1.</p><p>O'Donnell J, Ekman E, Spalding W et al. The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies. J Int Med Res. 2009;37(6):1789–802. DOI: http://dx.doi.org/10.1177%2F147323000903700615.</p><p>Zweers M, de Boer T, van Roon J et al. Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Res Ther. 2011;13(5):239. DOI: 10.1186/ar3437. Epub 2011 Sep 21.</p><p>Luyten F, Geusens P, Malaise M et al. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Ann Rheum Dis. 2007;66(1):99–106. DOI: http://dx.doi.org/10.1136%2Fard.2006.052308.</p><p>Strand V, Simon L, Dougados M et al. Treatment of osteoarthritis with continuous versus intermittent celecoxib. J Rheumatol. 2011;38(12):2625–34. DOI: http://dx.doi.org/10.3899%2Fjrheum.110636.</p><p>Poddubnyy D, Song I, Sieper J. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 2009;27(4 Suppl 55):S148–51.</p><p>Wanders A, Heijde D, Landewe R et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756–65. DOI: http://dx.doi.org/10.1002%2Fart.21054.</p><p>Silverstein F, Faich G, Goldstein J et al. Gastrointestinal toxicity with celecoxib versus nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxid long-term arthritis safety study. JAMA. 2000;84:1247–55.</p><p>Singh G, Fort J, Goldstein J et al. Celecoxib versus naproxen and diclofenac in osteoarthri-tis patients: SUCCESS-1 study. Am J Med. 2006;119:255–66.</p><p>Moore R, Derry S, Makinson G, McQuay H. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systemic review and meta-analysis on information from company clinical reports. Arthritis Res Ther. 2005;7(3):S644–65. Epub 2005 Mar 24.</p><p>Simon L, Weaver A, Graham D. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized control trial. JAMA. 1999;282(20);1921–8. DOI: http://dx.doi.org/10.1001%2Fjama.282.20.1921.</p><p>Emery P, Zeidler H, Kvien T et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomized double-blind comparison. Lancet. 1999;354:2106–11.</p><p>Каратеев АЕ, Бочкова АГ, Румянцева ОА и др. Применение капсульной эндоскопии для оценки влияния мелоксикама и диклофенака на слизистую оболочку тонкой кишки у больных с анкилозирующим спондилитом: первый опыт. Научно-практическая ревматология. 2011;4:31–5. [Karateev AE, Bochkova AG, Rumyantseva OA и др. Use of capsule endoscopy to evaluate the effects of meloxicam and diclofenac on the small bowel musoca in patients with ankylosing spondylitis: the first experience. Rheumatology Science and Practice. 2011;4:31–5.]</p><p>Davies N, Saleh J, Skjodt N. Detection and prevention of NSAID-induced enteropathy. J Pharm Pharm Sci. 2000;3:137–55.</p><p>Maiden L, Thjodleifsson B, Seigal A et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007;5(9):1040–5. DOI: http://dx.doi.org/10.1016%2Fj.cgh.2007.04.031 .Epub 2007 Jul 10.</p><p>Sands G, Shell B, Zhang R. Adverse events in patients with blood loss: a pooled analysis of 51 clinical studies from the celecoxib clinical trial database. Open Rheumatol J. 2012;6:44–9.</p><p>Singh G, Agrawal N, Makinson G et al. Safety without borders: upper and lower gastrointestinal safety of celecoxib in a pooled analysis of 52 prospective, randomized, double-blinded, parallel-group clinical trials. EULAR-2010 THU0437.</p><p>Chan F, Lanas A, Scheiman J et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010;376(9736):173–9. DOI: http://dx.doi.org/10.1016%2FS0140-6736%2810%2960673-3.</p><p>Goldstein J, Eisen G, Lewis B et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3(2):133–41. DOI: http://dx.doi.org/10.1016%2FS1542-3565%2804%2900619-6.</p><p>Cryer B, Li C, Simon L et al. GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial. Am J Gastroenterol. 2012;108(3):392–400. DOI: http://dx.doi.org/10.1038%2Fajg.2012.467.</p><p>Castellsague J, Riera-Guardia N, Calingaert B et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127–46. DOI: 10.2165/11633470-000000000-00000.</p><p>Hochman J, Shah N. What Price Pain Relief? Circulation. 2006;113(25):2868–70. DOI: http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.634386.</p><p>Hermann M. Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs. Curr Rheumatol Rep. 2009;11(1):31–5. DOI: http://dx.doi.org/10.1007%2Fs11926-009-0005-5.</p><p>Trelle S, Reichenbach S, Wandel S et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086. DOI: 10.1136/bmj.c7086.</p><p>McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098. DOI: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27.</p><p>Varas-Lorenzo C, Riera-Guardia N, Calingaert B et al. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiolog Drug Saf. 2013;22:559–70. DOI: 10.1002/pds.3437.</p></div><br />
Review
For citations:
Karateev AE. Celecoxib: evaluation of its efficacy and safety in the second decade of the 21st century. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2013;7(4):54-61. (In Russ.) https://doi.org/10.14412/1996-7012-2013-2439
Views:
1636
Email this article 